Embry Holdings Limited (1388) AI Stock Analysis

0 Followers

Embry Holdings Limited

(HKEX:1388)

Select Model

Rating:42Neutral

Price Target:HKD 0.23▼(-4.17% Downside)

Action:upgraded

Date:11/07/26

The score is primarily constrained by persistent losses, negative cash generation, and weak technical momentum. Manageable leverage and oversold RSI provide limited offsets, but the negative P/E and absent dividend yield leave little valuation support.

Positive Factors

Strong Gross MarginsGross margins of roughly 70–75% indicate that the lingerie and intimate-apparel products retain strong underlying product economics. If management can improve operating discipline and restore scale, this margin structure could provide a solid foundation for rebuilding profitability over the next several quarters.

Negative Factors

Persistent UnprofitabilityPersistent operating and net losses show that strong gross margins are not translating into viable earnings. The gap points to elevated operating costs and weak operating leverage, creating a durable execution challenge that could continue consuming resources and limiting self-funded growth.

Embry Holdings Limited (1388) vs. iShares MSCI Hong Kong ETF (EWH)

Market Cap: HKD 99.27M
Dividend Yield: ―
Average Volume (3M): 72.76K
Price to Earnings (P/E): -0.4
Beta (1Y): 0.31
Revenue Growth: 5.51%
EPS Growth: 30.14%
Country: Hong Kong
Employees: 3,696
Sector: Consumer Cyclical
Sector Strength: 61
Industry: Apparel - Manufacturers

Embry Holdings Limited Business Overview & Revenue Model

Company Description

Embry Holdings Limited operates as an investment holding company primarily focused on the entire lifecycle of women's intimate apparel, encompassing design, research, development, manufacturing, and distribution. Its product offerings include brassie...

Embry Holdings Limited Financial Statement Overview

Summary

Financial performance is weak overall: persistent operating losses, a -21.6% TTM net margin, negative operating cash flow of HKD 26M, and declining equity outweigh manageable leverage and historically strong gross margins.

Income Statement

32Negative

Balance Sheet

65Positive

Cash Flow

28Negative

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.19B	1.17B	1.15B	1.28B	1.33B	1.65B
Gross Profit	823.14M	818.45M	848.67M	956.10M	1.00B	1.21B
EBITDA	-90.14M	-87.83M	-268.27M	15.40M	65.16M	131.00M
Net Income	-243.94M	-253.18M	-373.44M	-72.17M	-51.24M	-27.48M
Balance Sheet
Total Assets	2.45B	2.32B	2.37B	2.86B	2.98B	3.30B
Cash, Cash Equivalents and Short-Term Investments	229.35M	189.79M	163.43M	283.61M	380.18M	378.64M
Total Debt	574.60M	476.52M	363.43M	342.33M	384.05M	425.35M
Total Liabilities	892.35M	775.23M	642.66M	704.09M	704.47M	788.50M
Stockholders Equity	1.55B	1.55B	1.72B	2.16B	2.27B	2.52B
Cash Flow
Free Cash Flow	-45.33M	-37.17M	-90.39M	9.81M	116.54M	154.28M
Operating Cash Flow	-36.85M	-26.61M	-81.62M	37.95M	137.71M	166.04M
Investing Cash Flow	-50.05M	-17.95M	-8.73M	-17.00M	-27.45M	-11.54M
Financing Cash Flow	53.96M	41.05M	-3.11M	-101.46M	-74.50M	-215.72M

Embry Holdings Limited Technical Analysis

Technical Analysis SentimentNegative

Last Price0.24

Price Trends

50DMA0.25Negative

100DMA0.26Negative

200DMA0.31Negative

Market Momentum

MACD-0.00Negative

RSI24.56Positive

STOCH41.86Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1388, the sentiment is Negative. The current price of 0.24 is below the 20-day moving average (MA) of 0.24, below the 50-day MA of 0.25, and below the 200-day MA of 0.31, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 24.56 is Positive, neither overbought nor oversold. The STOCH value of 41.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:1388.

Embry Holdings Limited Peers Comparison

Overall Rating

UnderperformOutperform

Sector (61)

Financial Indicators

HK:1388 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:2313	69Neutral	HKD 63.50B	11.99	12.10%	4.90%	1.86%	-27.58%
Sector *	61Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
HK:2199	61Neutral	HKD 3.05B	10.87	9.33%	6.40%	-1.56%	53.99%
HK:2298	60Neutral	HKD 548.36M	3.75	5.83%	6.40%	-1.84%	29.22%
HK:0311	50Neutral	HKD 351.60M	4.17	6.65%	7.38%	0.41%	―
HK:3322	44Neutral	HKD 267.16M	-1.97	-10.95%	―	-16.20%	-324.90%
HK:1388	42Neutral	HKD 101.38M	-0.41	-15.72%	―	5.51%	30.14%

* Consumer Cyclical Sector Average

Performance Comparison

HK:1388 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
HK:1388	Embry Holdings Limited	0.24	-0.14	-36.84%
HK:2313	Shenzhou International Group Holdings	42.46	-24.87	-36.94%
HK:0311	Luen Thai Holdings Limited	0.34	0.15	78.95%
HK:3322	Win Hanverky Holdings Limited	0.21	-0.00	-0.95%
HK:2199	Regina Miracle International (Holdings) Limited	2.50	0.50	24.81%
HK:2298	Cosmo Lady (China) Holdings Co. Ltd.	0.25	-0.06	-19.35%

Embry Holdings Limited Corporate Events

Embry Holdings Narrows Interim Loss as E-Commerce and Branding Drive Modest Growth

Aug 28, 2026

Embry Holdings Limited, a Hong Kong-listed intimate apparel manufacturer and retailer, focuses on lingerie and related products under brands including EMBRY FORM. The company has been shifting more resources to e-commerce channels while using celebri...

Embry Holdings Sets August Board Meeting to Review Interim Results and Dividend

Aug 13, 2026

Embry Holdings Limited has scheduled a board meeting for 28 August 2026 to review and approve the unaudited interim results for the six months ended 30 June 2026. The board will also consider the possible recommendation of an interim dividend, signal...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 07, 2026

Embry Holdings Limited AI Stock Analysis